Is it Finally Time to Buy Medical Properties Trust?
Medical Properties Trust (NYSE:MPW) is a REIT that focuses on…
Sell
50
ARCC Quote, Financials, Valuation and Earnings
Last price:
$22.10
Seasonality move
:
1.91%
Day range:
$22.11 - $22.37
52-week range:
$19.32 - $23.84
Dividend yield:
8.59%
P/E ratio:
9.13x
P/S ratio:
8.17x
P/B ratio:
1.15x
Volume:
2.8M
Avg. volume:
4.5M
1-year change:
9.18%
Market cap:
$15.3B
Revenue:
$1.7B
EPS (TTM):
$2.45
Analysts' Opinion
-
Consensus RatingAres Capital has received a consensus rating of Buy. The company's average rating is a Buy based on 7 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $23.42, Ares Capital has an estimated upside of 4.75% from its current price of $22.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $22.00 representing 100% downside risk from its current price of $22.36.
Fair Value
-
According to the consensus of 10 analysts, Ares Capital has 4.75% upside to fair value with a price target of $23.42 per share.
ARCC vs. S&P 500
-
Over the past 5 trading days, Ares Capital has overperformed the S&P 500 by 2.43% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Ares Capital does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Ares Capital revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Ares Capital reported revenues of $393M.
Earnings Growth
-
Ares Capital earnings have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Ares Capital reported earnings per share of $0.55.
Enterprise value:
28.4B
EV / Invested capital:
1.05x
Price / LTM sales:
8.17x
EV / EBIT:
12.61x
EV / Revenue:
16.64x
PEG ratio (5yr expected):
0.71x
EV / Free cash flow:
-13.36x
Price / Operating cash flow:
21.99x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
5.88%
Net Income Margin (TTM):
89.11%
Return On Equity:
12.36%
Return On Invested Capital:
6.06%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Income Statement | ||||||
| Revenue | $745M | $1.6B | $1.7B | $444M | $393M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $1.20 | $2.67 | $2.45 | $0.70 | $0.55 | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $477M | $594M | $483M | $796M | $1.2B | |
| Total Assets | $16.2B | $20.8B | $22.4B | $23.8B | $28.3B | |
| Current Liabilities | $447M | $727M | $356M | $430M | $865M | |
| Total Liabilities | $9B | $12B | $12.8B | $12.6B | $14.9B | |
| Total Equity | $7.2B | $8.9B | $9.6B | $11.2B | $13.4B | |
| Total Debt | $8.6B | $11.1B | $12.3B | $11.9B | $13.8B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$1.4B | $511M | -$2.1B | -$359M | -$268M | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | $1.2B | -$284M | $2.4B | $318M | $504M | |
| Free Cash Flow | -$1.4B | $511M | -$2.1B | -$359M | -$268M | |
ARCC
Sector
Market Cap
$15.3B
$625.8M
Price % of 52-Week High
93.79%
86.55%
Dividend Yield
8.59%
1.95%
Shareholder Yield
-3.48%
3.76%
1-Year Price Total Return
9.18%
9.43%
Beta (5-Year)
1.012
0.712
Dividend yield:
8.59%
Annualized payout:
$1.92
Payout ratio:
74.84%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$22.00
200-day SMA
Buy
Level
$21.58
Bollinger Bands (100)
Buy
Level
21.51 - 23.01
Chaikin Money Flow
Buy
Level
214.8M
20-day SMA
Buy
Level
$22.22
Relative Strength Index (RSI14)
Buy
Level
50.95
ADX Line
Buy
Level
16.13
Williams %R
Neutral
Level
-29.0667
50-day SMA
Sell
Level
$22.78
MACD (12, 26)
Sell
Level
-0.20
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
137.1M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.9705)
Buy
CA Score
(Annual)
Level (-0.1795)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Buy
Ohlson Score
Level (-0.824)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Ares Capital Corp is a United States-based closed-ended specialty finance company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company focuses on investing primarily in first lien senior secured loans (including unitranche loans, which are loans that combine both senior and subordinated debt, generally in a first lien position) and second lien senior secured loans. In addition to senior secured loans, the company also invests in subordinated loans and preferred equity, it also makes common equity investments.
Stock Forecast FAQ
In the current month, ARCC has received 7 Buy ratings 3 Hold ratings, and 0 Sell ratings. The ARCC average analyst price target in the past 3 months is $23.42.
-
Where Will Ares Capital Stock Be In 1 Year?
According to analysts, the consensus estimate is that Ares Capital share price will rise to $23.42 per share over the next 12 months.
-
What Do Analysts Say About Ares Capital?
Analysts are divided on their view about Ares Capital share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Ares Capital is a Sell and believe this share price will drop from its current level to $22.00.
-
What Is Ares Capital's Price Target?
The price target for Ares Capital over the next 1-year time period is forecast to be $23.42 according to 10 Wall Street analysts, 7 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is ARCC A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Ares Capital is a Buy. 7 of 10 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of ARCC?
You can purchase shares of Ares Capital via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Ares Capital shares.
-
What Is The Ares Capital Share Price Today?
Ares Capital was last trading at $22.10 per share. This represents the most recent stock quote for Ares Capital. Yesterday, Ares Capital closed at $22.36 per share.
-
How To Buy Ares Capital Stock Online?
In order to purchase Ares Capital stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Signet Jewelers Stock Go Up So Much?
Signet Jewelers (NYSE:SIG) is the largest diamond retailer in the…
Why Did HealthEquity Stock Fall So Much?
HealthEquity (NASDAQ:HQY) is a fintech company that acts as an…
Stock Ideas
Buy
56
Is AAPL Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 37x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
44
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
69
CNXC alert for Mar 28
Concentrix [CNXC] is down 12.39% over the past day.
Buy
74
SLNO alert for Mar 28
Soleno Therapeutics [SLNO] is up 6.8% over the past day.
Buy
51
CAR alert for Mar 28
Avis Budget Group [CAR] is up 0.71% over the past day.
